First Wave BioPharma Inc

Company Profile

First Wave BioPharma Inc had its IPO on 2016-10-11 under the ticker symbol FWBI.

The company operates in the Healthcare sector and Biotechnology industry. First Wave BioPharma Inc has a staff strength of 10 employees.

Stock update

Shares of First Wave BioPharma Inc opened at $0.41 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.38 - $0.42, and closed at $0.4.

This is a -0.6% slip from the previous day's closing price.

A total volume of 331,813 shares were traded at the close of the day’s session.

In the last one week, shares of First Wave BioPharma Inc have increased by +38.14%.

First Wave BioPharma Inc's Key Ratios

First Wave BioPharma Inc has a market cap of $2.07 million, indicating a price to book ratio of 2.8181 and a price to sales ratio of 0.

In the last 12-months First Wave BioPharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-6104937. The EBITDA ratio measures First Wave BioPharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, First Wave BioPharma Inc’s operating margin was 0% while its return on assets stood at -92.89% with a return of equity of -2343.29%.

In Q2, First Wave BioPharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

First Wave BioPharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0.0022

PEG

Its diluted EPS in the last 12-months stands at $134.86 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into First Wave BioPharma Inc’s profitability.

First Wave BioPharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.1113. Its price to sales ratio in the trailing 12-months stood at 0.

First Wave BioPharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$4.33 million

Total Liabilities

$3.26 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

First Wave BioPharma Inc ended 2025 with $4.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $4.33 million while shareholder equity stood at $881960.00.

First Wave BioPharma Inc ended 2025 with $0 in deferred long-term liabilities, $3.26 million in other current liabilities, 421.00 in common stock, $-176793574.00 in retained earnings and $1.68 million in goodwill. Its cash balance stood at $1.24 million and cash and short-term investments were $1.24 million. The company’s total short-term debt was $217,042 while long-term debt stood at $0.

First Wave BioPharma Inc’s total current assets stands at $2.35 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.59 million and inventory worth $0.

In 2025, First Wave BioPharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, First Wave BioPharma Inc paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$0.4

52-Week High

$20.6506

52-Week Low

$0.273

Analyst Target Price

$126

First Wave BioPharma Inc stock is currently trading at $0.4 per share. It touched a 52-week high of $20.6506 and a 52-week low of $20.6506. Analysts tracking the stock have a 12-month average target price of $126.

Its 50-day moving average was $0.62 and 200-day moving average was $2.78 The short ratio stood at 0.12 indicating a short percent outstanding of 0%.

Around 77.4% of the company’s stock are held by insiders while 165.4% are held by institutions.